A comprehensive two-decades long study of 695 men living in Geelong found that gaining as little as three kilograms of weight over five years is linked to back pain and high rates of disability ten ...
Shares of Eli Lilly climbed Wednesday after the drugmaker detailed a study showing that its blockbuster weight-loss drug Zepbound helped patients shed more pounds than Wegovy from rival Novo Nordisk.